Last updated: 11/07/2018 17:06:33
A multicentre, randomised, double-blind, parallel group, 12 month study to compare the safety and tolerability of fluticasone propionate 500mcg twice daily with beclomethasone dipropionate 1000mcg twice daily administered via the pressurised inhaler in adults with severe chronic asthma
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A multicentre, randomised, double-blind, parallel group, 12 month study to compare the safety and tolerability of fluticasone propionate 500mcg twice daily with beclomethasone dipropionate 1000mcg twice daily administered via the pressurised inhaler in adults with severe chronic asthma
Trial description: A multicentre, randomised, double-blind, parallel group, 12 month study to compare the safety and tolerability of fluticasone propionate 500mcg twice daily with beclomethasone dipropionate 1000mcg twice daily administered via the pressurised inhaler in adults with severe chronic asthma
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Lorentzen KA, Van Helmond JLM, Bauer K, Langaker KE, Bonifazi F, Harris TAJ. Fluticasone propionate 1mg daily and beclomethasone dipropionate 2mg daily: A comparison over 1 year. Respir Med 1996; 90 (10): 609-617.
Medical condition
Asthma
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
September 1991 to March 1993
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1993-11-03
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website